Materials & Resources » Chemicals | Hubei Biocause Pharmaceutical Co. Ltd.

Hubei Biocause Pharmaceutical Co. Ltd. A | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Net Property, Plant & Equipment
619
463
350
600
699
828
Total Assets
2,203
2,108
2,409
117,835
138,734
161,906
Deferred Taxes
46
9
70
1,116
811
Other Liabilities
177
129
97
44,235
31,553
Total Liabilities
750
599
608
97,421
112,014
Common Equity (Total)
1,396
1,449
1,740
13,802
19,337
Total Shareholders' Equity
1,396
1,449
1,740
13,802
19,337
Total Equity
1,436
1,490
1,784
20,398
26,705
Liabilities & Shareholders' Equity
2,203
2,108
2,409
117,835
138,734
Accumulated Minority Interest
40
41
44
6,596
7,368
Non-Equity Reserves
16
19
18
16
15
Other Assets (Including Intangibles)
724
1,556
1,187
21,050
19,795
54,366
Investment in Unconsolidated Subs.
690
-
742
8,280
10,891
12,984
Total Debt
573
449
373
1,784
7,789
Cash Only
124
59
62
11,714
11,932
18,317
Total Investment Assets
-
-
-
75,838
95,112
73,960
Premium Balance Receivables
-
-
-
283
266
261
Insurance Policy Liabilities (Insurance)
-
-
-
50,216
71,821

About Hubei Biocause Pharmaceutical Co.

View Profile
Address
No. 132 Yangwan Road
Jingmen Hubei 448000
China
Employees -
Website http://www.biocause.com
Updated 07/08/2019
Hubei Biocause Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of chemical products and medicinal raw materials. Its products include homatropine hydrobromide, thiotriazoline, lercanidipine hydrochloride, barnidipine hydrochloride, mitoxantrone hydrochloride, hyoscyamine sulfate, balsalazide sodium, oxaprozin, homatropine methyl bromide, flumazenil, milrinone, granisetron hydrochloride and others. The company was founded on November 18, 1993 and is headquartered in Jingmen, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.